mRNA vaccine developed against spike glycoprotein Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has shown remarkable effectiveness in the fight against coronavirus 19 (COVID-19). These...
In a recent study posted to the bioRxiv preprint* server, researchers in Japan investigated the proliferative capacity, transmissibility, and pathogenicity of the severe acute respiratory syndrome...
A review article published in a magazine Signaling and targeted therapyscientists discuss host metabolic alterations caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and their...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of the coronavirus disease 2019 (COVID-19) pandemic, has claimed more than 6.92 million lives and infected more...
A recent study published in the journal PNASresearchers found that the tight junction (TJ) protein occludin (OCLN) is critical for direct cell-to-cell transmission in the host...
In a recent study published in Nature Communications, Researchers have developed a new intranasal vaccine candidate, DelNS1-RBD4N-DAF, against coronavirus disease 2019 (COVID-19). This live attenuated influenza...
Recent Comments